Myth 3: Can IBD patients get married and have children?
IBD is not contagious and isn’t considered a genetic disease, but it does have a genetic predisposition. Studies have shown that the risk of children with IBD is 2-8 times higher than the average person. However, we know that hypertension and diabetes are also genetically predisposed, and IBD patients can still get married and have children. Pregnancy for IBD patients may be more challenging, but with pre-pregnancy evaluation and medication management during pregnancy (medication should not be discontinued at will and should be adjusted under a doctor’s guidance), the vast majority of patients can have healthy babies.
Myth 4: Can I stop medication once IBD symptoms resolve?
Wrong. IBD requires long-term “maintenance treatment,” and stopping medication without authorization can lead to relapses. For example, while biologics can quickly control inflammation, abrupt discontinuation can trigger “rebound inflammation,” a rapid resurgence of intestinal inflammation, with symptoms even more severe than before treatment. Studies have shown that regular medication use can increase the five-year relapse-free rate for ulcerative colitis patients to over 60%.
Myth 5: Does IBD necessarily lead to cancer?
Not necessarily. Long-term, uncontrolled inflammation can indeed increase the risk of colorectal cancer, up to ten times that of the general population. However, standardized treatment and regular monitoring are key to cancer prevention. Colonoscopy surveillance is recommended every one to two years, and early-stage cancers can be removed endoscopically. Patients don’t need to panic, but they should remain vigilant and work with their doctor to develop a long-term management plan. Remember: with scientific management, IBD is preventable and controllable!
Myth 6: Can surgery cure IBD?
No. Surgery is only indicated for complications (such as intestinal perforation or cancer) or for those who are ineffective with medication, but it cannot cure the disease. For example, Crohn’s disease has a high recurrence rate after surgery, necessitating lifelong follow-up. Data show that approximately 40% of IBD patients require at least one surgery, but they still require medication after surgery.
